
|Videos|October 11, 2016
Measuring Outcomes in Atopic Dermatitis
Advertisement
Episodes in this series

Panelists Peter L. Salgo, MD; Jonathan Silverberg, MD, PhD, MPH; Cheryl Allen, BS Pharm, MBA; and Jeffrey D. Dunn, PharmD, MBA, discuss the safety and selection of long-term treatments in atopic dermatitis.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Paradigm Shift in Lipid Management: Highlights from the NLA 2026 Scientific Sessions Opening Session
2
ATTR-CM Red Flags, Treatment Evidence, and the Pharmacist's Role in Care
3
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant Treatment of High-Risk Clear Cell RCC
4
Final CLL14 Analysis Confirms Durable Benefit With Fixed-Duration Venetoclax-Obinutuzumab in Frontline CLL
5






















































































































































